Subgroup analyses were carried out based on patient age, WHO classification, karyotypes and mutation status of six genes related to MDS (DNMT3A, IDH1, IDH2, SF3B1, SRSF2 and U2AF1). This evidence concerns the gene SF3B1 and myelodysplastic syndrome.